Henry Schein reported its Q4 2021 financial results revealing a 5.2% increase in sales year over year despite the impact of the pandemic.
Henry Schein reported record fourth-quarter non-GAAP financial results from continuing operations with total net sales for the quarter of $3.3 billion, up 5.2% compared with the fourth quarter of 2020.
GAAP net income attributable to Henry Schein for the fourth quarter of 2021 was $147.2 million, or $1.05 per diluted share, compared with prior-year at $141.9 million, or $0.99 per diluted share.
Total net sales from continuing operations for 2021 were $12.4 billion, an increase of 22.6% compared with 2020.
“Despite the impact of the global COVID-19 pandemic, we are pleased to report excellent full-year 2021 financial results, including an outstanding fourth-quarter that exceeded our expectations,” said Stanley Bergman, chairman of the board and chief executive officer of Henry Schein.
Global dental sales for the fourth quarter of 2021 were $2 billion, an increase of 9.4% compared with the prior-year period.
In North America, dental consumable merchandise internal sales increased 10.3% and 10.1% when excluding sales of PPE and COVID-19 related products.
“North America dental consumable merchandise internal sales growth in local currencies with and without PPE and COVID-19 related products was strong in the fourth quarter,” said Bergman. “This growth reflects the impact of some modest price increases as well as the contribution from two large contracts with dental service organizations awarded in 2021.”